Ads

 

Ads

 

Ads

 

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Biopharmaceutical Companies 2026
Metatag Abstract
World Largest Biopharmaceutical Companies by Market Cap in 2026, World Top Biopharmaceutical Companies by Market Cap in 2026.
  1. Annexon Inc.

    World Rank (Aug-2026)
    9,234
    Market Cap (Aug-2026)
    1.003 Billion USD
    World Rank (Jan-05-2024)
    14,389
    Market Cap (Jan-05-2024)
    0.375 Billion USD
    World Rank (Jul-30-2023)
    18,916
    Market Cap (Jul-30-2023)
    0.170 Billion USD
    World Rank (Dec-25-2022)
    16,605
    Market Cap (Dec-25-2022)
    0.260 Billion USD
    World Rank (Jan-07-2022)
    16,216
    Market Cap (Jan-07-2022)
    0.32 Billion USD
    Annual Operating Income in USD
    -216 Million USD
    Annual Net Income in USD
    -207 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Annexon Biosciences is a Clinical Stage Biopharmaceutical company discovering, developing and commercializing breakthrough therapeutics for autoimmune and neurodegenerative disease. It is having 38 employees as on September 2020. The headquarters is in USA.
  2. Kura Oncology

    World Rank (Aug-2026)
    9,405
    Market Cap (Aug-2026)
    0.966 Billion USD
    World Rank (Jan-05-2024)
    7,868
    Market Cap (Jan-05-2024)
    1.161 Billion USD
    World Rank (Jul-30-2023)
    10,368
    Market Cap (Jul-30-2023)
    0.739 Billion USD
    World Rank (Dec-25-2022)
    9,716
    Market Cap (Dec-25-2022)
    0.781 Billion USD
    World Rank (Jan-07-2022)
    10,231
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    67 Million USD
    Annual Operating Income in USD
    -304 Million USD
    Annual Net Income in USD
    -279 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Kura Oncology is a Clinical Stage Biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company total assets is 265.6 million USD and 134 employees as on 2019. The headquarters is in USA.
  3. Chemocentryx

    World Rank (Aug-2026)
    9,478
    Market Cap (Aug-2026)
    0.951 Billion USD
    World Rank (Jan-05-2024)
    5,410
    World Rank (Jul-30-2023)
    5,410
    World Rank (Dec-25-2022)
    5,410
    World Rank (Jan-07-2022)
    5,410
    Market Cap (Jan-07-2022)
    2.56 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Operating Income in USD
    -130 Million USD
    Annual Net Income in USD
    -132 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    Company Profile
    ChemoCentryx is a Biopharmaceutical company. It portfolio of therapeutics in areas such as orphan and rare diseases, chronic kidney disease, immuno oncology and inflammatory and autoimmune diseases. The headquarters is in USA.
  4. Olema Pharmaceuticals Inc.

    World Rank (Aug-2026)
    9,573
    Market Cap (Aug-2026)
    0.930 Billion USD
    World Rank (Jan-05-2024)
    10,291
    Market Cap (Jan-05-2024)
    0.733 Billion USD
    World Rank (Jul-30-2023)
    15,099
    Market Cap (Jul-30-2023)
    0.343 Billion USD
    World Rank (Dec-25-2022)
    21,255
    Market Cap (Dec-25-2022)
    0.107 Billion USD
    World Rank (Jan-07-2022)
    16,820
    Market Cap (Jan-07-2022)
    0.29 Billion USD
    Annual Operating Income in USD
    -179 Million USD
    Annual Net Income in USD
    -162 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Olema Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of a transformational generation of targeted therapies for women’s cancers. The headquarters is in USA.
  5. Changchun BCHT Biotechnology Co.

    World Rank (Aug-2026)
    9,643
    Market Cap (Aug-2026)
    0.914 Billion USD
    World Rank (Jan-05-2024)
    4,284
    Market Cap (Jan-05-2024)
    3.088 Billion USD
    Headquarters Country
    Company Profile

    Biopharmaceutical company with headquarters is in China.

  6. Peptidream

    World Rank (Aug-2026)
    9,690
    Market Cap (Aug-2026)
    0.902 Billion USD
    World Rank (Jan-05-2024)
    7,512
    Market Cap (Jan-05-2024)
    1.258 Billion USD
    World Rank (Jul-30-2023)
    6,400
    Market Cap (Jul-30-2023)
    1.676 Billion USD
    World Rank (Dec-25-2022)
    6,147
    Market Cap (Dec-25-2022)
    1.649 Billion USD
    World Rank (Jan-07-2022)
    5,361
    Market Cap (Jan-07-2022)
    2.59 Billion USD
    Annual Revenue in USD
    68 Million USD
    Annual Net Income in USD
    26 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    PeptiDream is a Biopharmaceutical company. It is the platform which enables the production of highly diverse non standard peptide libraries with high efficiency for the identification of highly potent and selective hit candidates which then can be developed into peptide based, small molecule based or peptide drug conjugate based therapeutics. The headquarters is in Japan.

Share

Ads